tion of mutant Ataxin 1 protein is delayed until after postnatal day 14, it would appear that Purkinje cell neurons are much better equipped to tolerate exposure to toxic misfolded proteins. It is very intriguing that the window is so narrow, as the presented data suggest that large amounts of Ataxin 1 protein do not appear until postnatal day 10. Nonetheless, the presence of mutant protein for scarcely 5 days is sufficient to elicit this profound toxic effect. In the polyQ repeat diseases HD and SBMA, it has been proposed that the normal function of the disease protein is required for preventing or retarding progression of the degenerative phenotype (Cattaneo et al., 2005; Thomas et al., 2006) . As both the huntingtin protein and the androgen receptor protein appear important for neurons during development, diminished normal function of these proteins due to polyQ expansions during development could place adult neurons at heightened risk of degeneration when forced to deal with polyQ gain-of-function toxicity. For these reasons, defining the normal functions and interactions of dominant disease proteins may shed light upon processes of neurodegeneration and, perhaps, even pathways of cell type specificity in the CNS. At synapses, neurotransmission is mediated by exocytosis of synaptic vesicles that are filled with neurotransmitters (Katz, 1969) . Synaptic vesicles occupy the presynaptic terminal and are unusually abundant, so much so that the brain could be considered a micromolar solution of synaptic vesicles. Because of their abundance and uniform size, synaptic vesicles are easy to purify and characterize, which has made them among the best characterized organelles in biology. From their initial description, synaptic vesicles have been viewed as a model organelle that could be used to elucidate general principles of membrane traffic (Südhof and Jahn, 1991) . This promise was realized early on with the discovery of SNARE proteins that mediate membrane fusion events, and of synaptotagmins that control the triggering of fusion by Ca 2+ . The paper presented in this issue by Takamori et al. (2006) Takamori et al. (2006) study is the first to define the overall structure of an organelle in quantitative terms and has several important implications. The results confirm and extend previous studies demonstrating that a surprisingly high number of SNARE and Rab proteins are present on synaptic vesicles (see Fischer von Mollard et al., 1994; Walch-Solimena et al., 1995; Antonin et al., 2000) . This finding not only partly explains why deletion of the SNARE protein synaptobrevin-although abolishing most exocytosis-does not completely block exocytosis (Schoch et al., 2001) but, more importantly, also supports the notion that synaptic vesicles must participate in more membrane trafficking reactions than just exo-and endocytosis. For example, the presence in synaptic vesicles of Rab and SNARE proteins, such as Rab5 and Vti1b, which are involved in endosomal fusion reactions, demonstrates that the vesicles must undertake occasional excursions to endosomes during their cycles of exo-and endocytosis. These excursions may serve to "proofread" the composition of the vesicles and to sort out unwanted and/or damaged vesicle components. Moreover, the presence of multiple SNARE proteins involved in different types of fusion reactions suggests that synaptic vesicles are able to keep the various SNARE proteins apart by a specific mechanism and to use only the correct ones for a given trafficking reaction. As an aside, this finding provides additional evidence that the specificity of membrane traffic cannot be encoded by the SNARE proteins themselves but must be mediated at least in part by the regulators of SNARE proteins in the synapse, such as the membrane fusion protein Munc-18-1 (Hata et al., 1993) . In addition, the fact that only a single copy of the proton pump is present argues against a second function of its subunits in membrane fusion in addition to its well-established role in the acidification of synaptic vesicles that is required for the loading of neurotransmitter (Hiesinger et al., 2005) . This is because it is difficult to imagine how 70 copies of the SNARE protein synaptobrevin/VAMP on the vesicle would act in fusion on a single proton pump in the cramped space of the vesicle/plasma membrane interface.
Like any important study, the Takamori et al. (2006) paper raises a number of questions. A general question is, what determines the identity of an organelle, and when can we tell whether a protein is a true component of that organelle (as opposed to a contaminant)? For those proteins that are not as abundant as SNARE proteins or synaptophysin, localization is not sufficient to answer this question, and a functional definition of the protein is needed before a protein can be considered to be a true vesicle component. In the same vein, what is the significance of multiple SNARE and Rab proteins on synaptic vesicles? As noted above, this finding confirms a participation of synaptic vesicles in endosomal trafficking in addition to exo-and endocytosis. However, some of the SNARE and Rab proteins on the vesicles, such as Rab7, are not known to participate in either plasma membrane or endosomal fusion reactions, suggesting that synaptic vesicles may be more complex than currently envisioned and may participate in additional, as yet unknown, trafficking reactions-for example, reactions involving lysosomes.
A third and equally important question is how synaptic vesicles in different types of synapses differ from each other. Significant functional and structural evidence indicates that vesicles are not identical. For example, GABAergic and glutamatergic vesicles exhibit distinct shapes in electron micrographs (Gray, 1959) , indicating that these vesicles must differ in composition beyond their content. Do synaptic vesicles exhibit microheterogeneity-for example, in the number of synaptobrevin copies per vesicle or the presence of peripheral proteins, which may affect the probability of vesicle release? This would explain the observation that the release probability of vesicles is heterogeneous. Moreover, how do synaptic vesicles differ from other secretory organelles that are subject to Ca 2+ -triggered exocytosis? The quantitative description of the composition of an average synaptic vesicle is a pioneering achievement that sets the stage for creating an equally complete functional definition of the components and for understanding their diversity. This endeavor is underway and will be greatly aided by the establishment of synaptic vesicles as a reference organelle. Moreover, several findings by Takamori et al. (2006) may be applicable to all organelles and membrane structures, thereby forming the basis for future studies on how such organelles and membranes are constructed and how they function.
Protein folding in cells is facilitated by several elegant chaperone machines that improve folding efficiency and minimize the occurrence of misfolded proteins in a crowded macromolecular environment. The central components of these machines are finely tuned by regulators, or cochaperones, that balance the kinetic and thermodynamic constraints of client proteins and thus create an environment (termed folding solvent) to optimize correct folding (Kelly and Balch, 2006) . Many components of this system also recognize misfolded proteins and facilitate their degradation through the ubiquitin proteasome system. These competing pathways for protein maturation and degradation intersect in the endoplasmic reticulum (ER), where nearly a third of the cellular proteome is synthesized, folded, and packaged for transport (Younger et al., 2006) . In this issue, Wang et al., (2006) provide new insight into the complexity of protein networks that populate the secretory pathway. They identify new factors that govern the fate of the cystic fibrosis transmembrane conductance regulator (CFTR), an apical membrane ATP-regulated chloride channel whose misfolding is implicated in cystic fibrosis.
Cystic fibrosis is an inherited disease of epithelial tissues caused primarily by point mutations that disrupt CFTR folding and delivery to the plasma membrane (Cheng et al., 1990) . CFTR folding takes place in the ER and requires the precise organization of two transmembrane domains and three cytosolic domains prior to export (Xiong et al., 1997) . In most cells, this process is both complex and inefficient (ure 1). Degradation approaches 100% for the major disease-related mutant, ∆F508, which is found in more than 90% of individuals with cystic fibrosis. Once folded, however, ∆F508 CFTR can traffic to the plasma membrane and partially restore chloride transport. Thus, interventions that could restore ∆F508 folding are of major clinical interest. Wang et al., (2006) now address this problem using multidimensional protein identification technology (MudPIT) to identify nearly 200 proteins (the "interactome") from four different cell types that coimmunoprecipitate with either wild-type or ∆F508 CFTR. Some of these interactions were either known or predicted based on prior studies of CFTR stability, trafficking, and endocytosis. However, the largest group-more than two-thirds of the proteins identified-have no known function related to CFTR. Even though some known interactions were not identified in this screen, which indicates that the total interactome is not yet complete, these data provide a valuable starting point for further study. Notably, the presence of several elaborate
